N,N′-Diisoprophyl phosphordiamide fluoride
- Product NameN,N′-Diisoprophyl phosphordiamide fluoride
- CAS371-86-8
- CBNumberCB5851771
- MFC6H16FN2OP
- MW182.18
- EINECS206-742-3
- MDL NumberMFCD00801119
- MOL File371-86-8.mol
Chemical Properties
| Melting point | 65° |
| Boiling point | 125.5°C |
| Density | 1.2 g/cm3(Temp: 25 °C) |
| pka | -2.71±0.70(Predicted) |
| form | solid |
| Water Solubility | 74.07g/L(temperature not stated) |
| EWG's Food Scores | 4 |
| FDA UNII | 24MJP5H3YN |
| EPA Substance Registry System | Mipafox (371-86-8) |
Safety
| Symbol(GHS) |
|
| Signal word | Danger |
| Hazard statements | H370 |
| Precautionary statements | P260-P264-P270-P307+P311-P321-P405-P501 |
| Hazard Codes | T+ |
| Risk Statements | 39/26/27/28 |
| Safety Statements | 13-45 |
| RIDADR | 2783 |
| HazardClass | 6.1(b) |
| PackingGroup | III |
| Hazardous Substances Data | 371-86-8(Hazardous Substances Data) |
| Toxicity | Formerly used as a systemic insecticide. Its use was discontinued because of severe delayed neuropathy hazard in humans. The oral LD50/LC50 in rabbits is 100 mg/kg. Toxic action is as a neurotoxicant with both acute and delayed actions, acting as a cholinesterase inhibitor (acute toxicity) and as a neurotoxic esterase inhibitor (possibly linked to delayed toxicity). Symptoms in humans are typical anticholinesterase symptoms. Therapy is supportive as well as atropine sulfate and 2-PAM. |